Warfarin and its interactions with foods, herbs and other dietary supplements

Bibliography

• ANSELL J, HIRSH J, POLLER L, BUSSEY H, JACOBSON A, HYLEK E: The Pharmacology and management of the vitamin K antagonists: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest (2004) 126:204S-233S.
   PubMed Web of Science ®Google Scholar
• PRODUCT INFORMATION: Coumadin (warfarin). Princeton, NJ: Bristol-Myers Squibb Co. (2002).
   Google Scholar
• NUTESCU EA, SHAPIRO NL, CHEVALIER A, AMIN AN: A pharmacologic overview of current and emerging anticoagulants. Cleve. Clin. J. Med. (2005) 72(Suppl. 1):S2-S6.
   PubMedGoogle Scholar
• HIGASHI MK, VEENSTRA DL, KONDO LM et al.: Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA (2002) 287(13):1690-1698.
   PubMed Web of Science ®Google Scholar
• YASAR U, ELIASSON E, DAHL ML, JOHANSSON I, INGELMAN-SUNDBERG M, SJOQVIST F: Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population. Biochem. Biophys. Res. Commun. (1999) 254(3):628-631.
   PubMed Web of Science ®Google Scholar
• RIEDER MJ, REINER AP, GAGE BF et al.: Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N. Engl. J. Med. (2005) 352:2285-2293.
   PubMed Web of Science ®Google Scholar
• HOLBROOK AM, PEREIRA JA, LABIRIS R et al.: Systematic overview of warfarin and its drug and food interactions. Arch. Intern. Med. (2005) 165(10):1095-1106.
   PubMed Web of Science ®Google Scholar
• DIETARY SUPPLEMENT HEALTH AND EDUCATION ACT: 21 USC §343-2 (1994).
   Google Scholar
• ZUCKERMAN IH, STEINBERGER EK, RYDER PT, HAINES S: Herbal product use among anticoagulation clinic patients. Am. J. Health Syst. Pharm. (2002) 59:379-380.
   PubMed Web of Science ®Google Scholar
• RAMSAY NA, KENNY MW, DAVIES G, PATEL JP: Complimentary and alternative medicine use among patients starting warfarin. Br. J. Haemat. (2005) 130:777-780.
   PubMed Web of Science ®Google Scholar
• STYS T, STYS A, KELLY P, LAWSON W: Trends in use of herbal and nutritional supplements in cardiovascular patients. Clin. Cardiol. (2004) 27(2):87-90.
   PubMed Web of Science ®Google Scholar
• BLENDON RJ, DESROCHES CM, BENSON JM, BRODIE M, ALTMAN DE: American’s views on the use and regulation of dietary supplements. Arch. Intern. Med. (2001) 161(6):805-810.
   PubMed Web of Science ®Google Scholar
• SMITH L, ERNST E, EWINGS P, MYERS P, SMITH C: Co-ingestion of herbal medicines and warfarin. Br. J. Gen. Pract. (2004) 54:439-441.
   PubMed Web of Science ®Google Scholar
• DAILEY JH: Dietary considerations. In: Managing Oral Anticoagulation Therapy. Clinical and Operational Guidelines, Ansell JE, Oertel LB, Wittkowsky AK, (Eds.), Aspen Publishers, Gaithersburg, MD. (2003):36.1-36.9.
   Google Scholar
• BOVILL EG, FUNG M, CUSHMAN M: Vitamin K and oral anticoagulation: thought for food. Am. J. Med. (2004) 116:711-713.
   PubMed Web of Science ®Google Scholar
• WEIZMANN N, PETESON JW, HAYTOWITZ D et al.: Vitamin K content of fast foods and snack foods in the US diet. J. Food Compos. Anal. (2004) 17:379-384.
   Web of Science ®Google Scholar
• PETERSON JW, MUZZEY KL, HAYTOWITZ D et al.: Phylloquinone (Vitamin K1) and dihydrophylloquinone content of fats and oils. J. Am. Oil Chem. Soc. (2002) 79:641-646.
   Web of Science ®Google Scholar
• BOOTH SL, SUTTIE JW: Dietary intake and adequacy of vitamin K. J. Nutr. (1998) 128:785-788.
   PubMed Web of Science ®Google Scholar
• FRANCO V, POLANCZYK CA, CLAUSELL N, ROHDE LE: Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am. J. Med. (2004) 116:651-656.
   PubMed Web of Science ®Google Scholar
• SCONCE E, KHAN T, MASON J et al.: Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb. Haemost. (2005) 93:872-875.
   PubMed Web of Science ®Google Scholar
• KHAN T, WYNNE HA, WOOD P et al.: Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Br. J. Haematol. (2004) 124:348-354.
   PubMed Web of Science ®Google Scholar
• FERLAND G, SADOWSKI JA: Vitamin K1 (phylloquinone) content of edible oils: effects of heating and light exposure. J. Agric. Food Chem. (1992) 40:1869-1873.
   Web of Science ®Google Scholar
• UEMATSU T, NAGASHIMA S, NIWA M et al.: The effect of dietary fat content on oral bioavailability of vitamin K. J. Pharm. Sci. (1996) 85:1012-1016.
   PubMed Web of Science ®Google Scholar
• BECKEY NP, KORMAN LB, PARRA D: Effect of the moderate consumption of olestra in patients receiving long-term warfarin therapy. Pharmacotherapy (1999) 19:1075-1079.
   PubMed Web of Science ®Google Scholar
• BLICKSTEIN D, SHAKLAI M, INBAL A: Warfarin antagonism by avocado. Lancet (1991) 337:914-915.
   PubMed Web of Science ®Google Scholar
• WERMAN MJ, MOKADY S, NEEMAN I et al.: The effect of avocado oil on some liver characteristics in growing rats. Food Chem. Toxicol. (1989) 27:279-282.
   PubMed Web of Science ®Google Scholar
• BEATTY SJ, MEHTA BH, RODIS JL: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann. Pharmacother. (2005) 39:744-747.
   PubMed Web of Science ®Google Scholar
• BARTLE WR, MADORIN P, FERLAND G: Seaweed, vitamin K, and warfarin. Am. J. Healt. Syst. Pharm. (2001) 58:2300.
   PubMed Web of Science ®Google Scholar
• KUYKENDALL JR, HOULE MD, RHODES RS: Possible warfarin failure due to interaction with smokeless tobacco. Ann. Pharmacother. (2004) 38:595-597.
   PubMed Web of Science ®Google Scholar
• FRASER AG: Pharmacokinetic interactions between alcohol and other drugs. Clin. Pharmacokinet. (1997) 33:79-90.
   PubMed Web of Science ®Google Scholar
• WEATHERMON R, CRABB DW: Alcohol and medication interactions. Alcohol Res. Health. (1999) 23:40-54.
   PubMedGoogle Scholar
• HA CE, PETERSON CE, PARK DS et al.: Investigation of the effects of ethanol on warfarin binding to human serum albumin. J. Biomed. Sci. (2000) 7:114-121.
   PubMed Web of Science ®Google Scholar
• HAVRDA DE, MAI T, CHONLAHAN J: Enhanced antithrobmotic effect of warfarin associated with low-dose alcohol consumption. Pharmacotherapy (2005) 25(2):303-307.
   PubMed Web of Science ®Google Scholar
• ELKIERT H, GOMOLKA E: Coumarin compounds in Ammi majus L. callus cultures. Pharmazie (2000) 55(9):684-687.
   PubMed Web of Science ®Google Scholar
• MALHOTRA S, BAILEY DG, PAINE MF, WATKINS PB: Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin. Pharmacol. Ther. (2001) 69:14-23.
   PubMed Web of Science ®Google Scholar
• SULLIVAN DM, FORD MA, BOYDEN TW: Grapefruit juice and the response to warfarin. Am. J. Health Syst. Pharm. (1998) 55:1581-1583.
   PubMed Web of Science ®Google Scholar
• BARTLE WR: Grapefruit juice might still be a factor in warfarin response. Am. J. Health Syst. Pharm. (1999) 56:676.
   PubMed Web of Science ®Google Scholar
• BAILEY DG, DRESSER GK, BEND JR: Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin. Pharmacol. Ther. (2003) 73:529-537.
   PubMed Web of Science ®Google Scholar
• BAILEY DG, MALCOLM J, ARNOLD O et al.: Grapefruit juice-drug interactions. Br. J. Clin. Pharmacol. (1998) 46:101-110.
   PubMed Web of Science ®Google Scholar
• SUVARNA R, PIRMOHAMED M, HENDERSON L: Possible interaction between warfarin and cranberry juice. Br. Med. J. (2003) 327:1454.
   PubMed Web of Science ®Google Scholar
• GRANT P: Wafarin and cranberry juice: an interaction? J. Heart Valve Dis. (2004) 13:25-26.
   PubMed Web of Science ®Google Scholar
• WALSH KM: Getting to yes. J. Am. Geriatr. Soc. (2005) 53:1072.
   PubMed Web of Science ®Google Scholar
• DUTHIE GC, KYLE JA, JENKINSON AM et al.: Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J. Agric. Food Chem. (2005) 53:2897-2900.
   PubMed Web of Science ®Google Scholar
• WOSILAIT WD: Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between the free and bound drug and therapeutic levels. Eur. J. Clin. Pharmacol. (1976) 9:285-290.
   PubMed Web of Science ®Google Scholar
• GREENBLATT DJ, VON MOLTKE LL, PERLOFF ES et al.: Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin. Pharmacol. Ther. (2006) 79:125-133.
   PubMed Web of Science ®Google Scholar
• LAM AY, ELMER GW, MOHUTSKY MA: Possible interaction between warfarin and Lycium barbarum L. Ann. Pharmacother. (2001) 35:1199-1201.
   PubMed Web of Science ®Google Scholar
• YUE QY: Herbal drug curbicin and anticoagulant effect with and without warfarin: Possibly related to the vitamin E component. JAGS (2001) 49:838.
   PubMedGoogle Scholar
• CORRIGAN JJ JR, MARCUS JI: Coagualopathy associated with vitamin E ingestion. JAMA (1974) 230:1300-1301.
   PubMed Web of Science ®Google Scholar
• CORRIGAN JJ JR, ULFERS L: Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency. Am. J. Clinc. Nutr. (1981) 34:1701-1705.
   PubMed Web of Science ®Google Scholar
• KIM JM, WHITE RH: Effect of vitamin E on the anticoagulant response to warfarin. Am. J. Cardiol. (1996) 77:545-546.
   PubMed Web of Science ®Google Scholar
• CHESNEY CM, ELAM MB HERD JA et al.: Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT). Am. Heart J. (2000) 140:631-636.
   PubMed Web of Science ®Google Scholar
• FOSTER BC, FOSTER MS, VANDENHOEK S et al.: An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J. Pharm. Pharmaceut. Sci. (2001) 4:176-184.
   PubMed Web of Science ®Google Scholar
• PISCITELLI SC, BURSTEIN AH, WELDEN N, GALLICANO KD, FALLOON J: The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin. Infect. Dis. (2002) 34(2):234-238.
   PubMed Web of Science ®Google Scholar
• ROSE KD, CROISSANT PD, PARLIAMENT CF, LEVIN MP: Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery (1990) 26:880-882.
   PubMed Web of Science ®Google Scholar
• GERMAN K, KUMAR U, BLACKFORD HN: Garlic and the risk of TURP bleeding. Br. J. Urol. (1995) 76:518.
   PubMedGoogle Scholar
• SUNTER WH: Warfarin and garlic. Pharmaceut. J. (1991) 246:722.
   Google Scholar
• MACAN H, UYKIMPANG R, ALCONCEL M et al.: Aged garlic extract may be safe for patients on warfarin therapy. J. Nutr. (2006) 136:793S-795S.
   PubMed Web of Science ®Google Scholar
• LESHO EP, SAULLO L, UDVARI-NAGY S: A 76-year-old woman with erratic anticoagulation. Cleve. Clin. J. Med. (2004) 71(8):651-656.
   PubMed Web of Science ®Google Scholar
• ROWIN J, LEWIS SL: Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology (1996) 46:1775-1776.
   PubMed Web of Science ®Google Scholar
• GILBERT GJ: Ginkgo biloba (letter). Neurology (1997) 48:1137.
   PubMed Web of Science ®Google Scholar
• VALE S: Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet (1998) 352:36.
   PubMed Web of Science ®Google Scholar
• ROSENBLATT M, MINDEL J: Spontaneous hyphema associated with ingestion of Ginkgo biloba extract (letter). N. Engl. J. Med. (1997) 336:1108.
   PubMed Web of Science ®Google Scholar
• MATTHEWS MK: Association of Ginkgo biloba with intracerebral hemorrhage (letter). Neurology (1998) 50:1933.
   PubMed Web of Science ®Google Scholar
• SHINOZUKA K, UMEGAKI K, KUBOTA Y et al.: Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic P450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci. (2002) 70(23):2783-2792.
   PubMed Web of Science ®Google Scholar
• UMEGAKI K, SAITO K, KUBOTA Y, SANADA H, YAMADA K, SHINOZUKA K: Ginkgo biloba extract markedly induces pentoxyresorufin O-dealkylase activity in rats. Jpn. J. Pharmacol. (2002) 90(4):345-351.
   PubMedGoogle Scholar
• ENGELSEN J, NIELSEN JD, HANSEN KF: Effect of coenzyme Q10 and ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial. Ugeskr. Laeger. (2003) 165(18):1868-1871.
   PubMedGoogle Scholar
• MOHUTSKY MA, ANDERSON GD, MILLER JW et al.: Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. Am. J. Ther. (2006) 13:24-31.
   PubMed Web of Science ®Google Scholar
• GREENBLATT DJ, VON MOLTKE LL, LUO Y et al.: Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate. J. Clinc. Pharm. (2006) 46:214-221.
   PubMed Web of Science ®Google Scholar
• MONTERREY-RODRIGUEZ J, FELIU JF, MIVERA-MIRANDA GC: Interaction between warfarin and mango fruit. Ann. Pharmacother. (2002) 36:940-941.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI H, SHIMADA T: Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes. Xenobiotica (1999) 29:231-241.
   PubMed Web of Science ®Google Scholar
• GREBE HB, GREGORY PJ: Inhibition of warfarin anticoagulation associated with chelation therapy. Pharmacotherapy (2002) 22(8):1067-1069.
   PubMed Web of Science ®Google Scholar
• GRIER MT, MEYERS DG: So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy. Ann. Pharmacother. (1993) 27:1504-1509.
   PubMed Web of Science ®Google Scholar
• ANG-LEE MK, MOSS J, YUAN CS: Herbal medicines and perioperative care. JAMA (2001) 286:208-216.
   PubMed Web of Science ®Google Scholar
• PARK HJ, LEE JH, SONG YB, PARK KH: Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol. Pharm. Bull. (1996) 19:1434-1439.
   PubMed Web of Science ®Google Scholar
• KIMURA Y, OKUDA H, ARICHI S: Effects of various ginseng saponins on 5 hydroxytryptamine release and aggregation in human platelets. J. Pharm. Pharmacol. (1988) 40:838-843.
   PubMed Web of Science ®Google Scholar
• PARK HJ, RHEE MH, PARK KM, NAM KY, PARK KH: Effect of nonsaponin fraction from Panax ginseng on cGMP and thromboxane A2 in human platelet aggregation. J. Ethnopharmacol. (1995) 49:157-162.
   PubMed Web of Science ®Google Scholar
• HENDERSON GL, HARKEY MR, GERSHWIN ME, HACKMAN RM, STERN JS, STRESSER DM: Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci. (1999) 65(15):PL209-PL214.
   PubMed Web of Science ®Google Scholar
• JANETSKY K, MORREALE AP: Probable interactions between warfarin and ginseng. Am J Healt Syst Pharm. (1997) 54:692-693.
   PubMed Web of Science ®Google Scholar
• JIANG X, WILLIAMS KM, LIAUW WS et al.: Effect of St John’s wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br. J. Clin. Pharmacol. (2004) 57:592-599.
   PubMed Web of Science ®Google Scholar
• YUAN CS, WEI G, DEY L et al.: Brief communication: American ginseng reduces warfarin’s effect in healthy patients: a randomized, controlled trial. Ann. Intern. Med. (2004) 141(1):23-7.
   PubMed Web of Science ®Google Scholar
• AWANG DVC, FUGH-BERGMAN A: Herbal interactions with cardiovascular drugs. J. Cardiovasc. Nurs. (2002) 16(4):64-70.
   PubMedGoogle Scholar
• HENDERSON L, YUE QY, BERGQUIST C, GERDEN B, ARLETT P: St John’s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br. J. Clin. Pharmacol. (2002) 54:349-356.
   PubMed Web of Science ®Google Scholar
• GRONING R, BREITKREUTZ J, MULLER RS: Physico-chemical interactions between extracts of Hypericum perforatum L. and drugs. Eur. J. Pharm. Biopharm. (2003) 56:231-236.
   PubMed Web of Science ®Google Scholar
• BOOTH SL, SADOWSKI JA, PENNINGTON JAT: Vitamin K1 (phylloquinone) content of foods: a provisional table. J. Food Comp. Anal. (1993) 6:109-120.
   Google Scholar
• BOOTH SL, MADABUSHI HT, DAVIDSON KW: Tea and coffee brews are not significant dietary sources of vitamin K1 (phylloquinone). J. Am. Diet. Assoc. (1995) 95:82-83.
   PubMed Web of Science ®Google Scholar
• TAYLOR JR, WILT VM: Probable antagonism of warfarin by green tea. Ann. Pharmacother. (1999) 33:426-428.
   PubMed Web of Science ®Google Scholar
• ROZENFELD V, CRAIN JL: Possible augmentation of warfarin effect by glucosamine-chondroitin. Am. J. Health Syst. Pharm. (2004) 61:306-307.
   PubMed Web of Science ®Google Scholar
• WEIMANN G, LUBENOW N, SELLENG K et al.: Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia. Eur. J. Haematol. (2001) 66:195-199.
   PubMed Web of Science ®Google Scholar
• WILDE MI, MARKHAM A: Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. Drugs (1997) 54:903-924.
   PubMed Web of Science ®Google Scholar
• SCOTT GN: Interaction of warfarin with glucosamine-chondroitin. Am. J. Health Syst. Pharm. (2004) 61:1186.
   PubMedGoogle Scholar
• SHAW D, LEON C, KOLEV S, MURRAY V: Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf. (1997) 17(5):342-356.
   PubMed Web of Science ®Google Scholar
• IZZO AA, DI CARLO G, BORRELLI F, ERNST E: Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Intern. J. Cardio. (2005) 98:1-14.
   PubMed Web of Science ®Google Scholar
• HECK AM, DEWITT BA, LUKES AL: Potential interactions between alternative therapies and warfarin. Am. J. Health Syst. Pharm. (2000) 57:1221-1230.
   PubMed Web of Science ®Google Scholar
• LANDBO C, ALMDAL TP: Interaction between warfarin and coenzyme q10. Ugeskr. Laeger. (1998) 160:3226-3227.
   PubMedGoogle Scholar
• SPIGSET O: Reduced effect of warfarin caused by ubidecarenone. Lancet (1994) 334:1372-1373.
   Google Scholar
• ENGELSEN J, NIELSEN JD, WINTHER K: Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial. Thromb. Haemost. (2002) 87:1075-1076.
   PubMed Web of Science ®Google Scholar
• SETCHELL KD, CASSIDY A: Dietary isoflavones: biological effects and relevance to human health. J. Nutr. (1999) 129:758S-767S.
   PubMed Web of Science ®Google Scholar
• CAMBRIA-KIELY JA: Effect of soy milk on warfarin efficacy. Ann. Pharmacother. (2002) 36:1893-1896.
   PubMed Web of Science ®Google Scholar
• BOOTH SL, SADOWSKI JA, PENNINGTON JAT: Phylloquinone (vitamin K1) content of foods in the US Food and Drug Administration’s total diet study. J. Agric. Food Chem. (1995) 43:1574-1579.
   Web of Science ®Google Scholar
• ANTHONY MS: Soy and cardiovascular disease: Cholesterol lowering and beyond. J. Nutr. (2000) 130:662S-663S.
   PubMed Web of Science ®Google Scholar
• CHAN K, LO AC, YEUNG JH, WOO KS: The effects of danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. J. Pharm. Pharmacol. (1995) 47:402-406.
   PubMed Web of Science ®Google Scholar
• WANG Z, ROBERTS JM, GRANT PG, COLMAN RW, SCHREIBER AD: The effect of a medicinal Chinese herb on platelet function. Thromb. Haemost. (1982) 48:301-306.
   PubMed Web of Science ®Google Scholar
• CHENG TO: Warfarin danshen interaction. Ann. Thorac. Surg. (1999) 67:892-896.
   Google Scholar
• CHAN TY: Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann. Pharmacother. (2001) 35:501-504.
   PubMed Web of Science ®Google Scholar
• IZZAT MB, YIM APC, EL-ZUFARI MH: A taste of Chinese medicine. Ann. Thorac. Surg. (1998) 66:941-942.
   PubMed Web of Science ®Google Scholar
• TAM LS, CHAN TYK, LEUNG WK, CRITCHLEY JAJH: Warfarin interactions with Chinese traditional medicines; danshen and methyl salicylate medicated oil. Aust. NZ J. Med. (1995) 25:257.
   PubMedGoogle Scholar
• YU CM, CHAN JCN, SANDERSON JE: Chinese herbs and warfarin potentiation by ‘danshen’. J. Intern. Med. (1997) 241:337-339.
   PubMed Web of Science ®Google Scholar
• LO ACT, CHAN K, YEUNG JHK et al.: Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits. Eur. J. Drug Metab. Pharmacokinet. (1995) 201(1):55-60.
   Google Scholar
• HOULT JR, PAYA M: Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen. Pharmacol. (1996) 27:713-722.
   PubMedGoogle Scholar
• PAGE RL II, LAWRENCE JD: Potentiation of warfarin by dong quai. Pharmacotherapy (1999) 19:870-876.
   PubMed Web of Science ®Google Scholar
• ELLIS GR, STEPHENS MR: Untitled (photograph and brief case report). Br. Med. J. (1999) 319:650.
   Google Scholar
• LAMBERT JP, CORMIER A: Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy (2001) 21:509-512.
   PubMed Web of Science ®Google Scholar
• UNGER M, FRANK A: Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom. (2004) 18:2273-2281.
   PubMed Web of Science ®Google Scholar
• SOVAK M, SELIGSON AL, KONAS M et al.: Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J. Natl. Cancer Inst. (2002) 94:1275-1281.
   PubMed Web of Science ®Google Scholar
• WILLIAMSON EM: Drug interactions between herbal and prescription medicines. Drug Saf. (2003) 26:1075-1092.
   PubMed Web of Science ®Google Scholar
• WITTKOWSKY AK: A systematic review and inventory of supplement effects on warfarin and other anticoagulants. Thromb. Res. (2005) 117:81-86.
   PubMed Web of Science ®Google Scholar
• HU Z, YANG X, HO PC et al.: Herb-drug interactions: a literature review. Drugs (2005) 65(9):1239-1282.
   PubMed Web of Science ®Google Scholar
• SAMUELS N: Herbal remedies and anticoagulant therapy. Thromb. Haemost. (2005) 93(1):3-7.
   PubMed Web of Science ®Google Scholar
• BUCKLEY MS, GOFF AD, KNAPP WE: Fish oil interaction with warfarin. Ann. Pharmacother. (2004) 38(1):50-52.
   PubMed Web of Science ®Google Scholar